Right-wing federal appeal judges signal they support repeal of the no-cost preventive care mandate, all but guaranteeing a Supreme Court showdown.
Health Care
As the first-ever Medicare drug-price negotiations take shape, Big Pharma-backed Democrats want to limit the number of costly medicines regulators can target.
Following a lobbying blitz, Congress might punt all efforts to stop shadowy pharmacy benefit managers from inflating drug prices and killing small pharmacies.
A bombshell report reveals that taxpayers spent billions developing medicines that drugmakers say shouldn’t face Medicare price negotiations.
The government is finally attempting to regulate overpriced drugs, but venture capital firms don’t want to lose their lucrative hold on life-saving pharmaceuticals.
There’s a basic conflict of interest at the heart of American health care. We need to break up the industry to fix it.
Many health insurers’ online provider directories are inaccurate or out-of-date, to the detriment of patients and health care professionals alike.
Powerful companies are removing hundreds of medicines from insurance plans — and they’re spending millions to stop attempts at reform.
As mental health advocates pushed for a bill to expand insurance coverage, Blue Cross Blue Shield of Michigan lobbied against it.
Expert advice on how to navigate the growing pitfalls of Medicare, Medicaid, and the health insurance marketplace.